Ediang, Lyza May N.

HRN: 00-03-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2025
CEFUROXIME 500MG (TAB)
09/12/2025
09/18/2025
ORAL
500mg
Q12
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines